Ionis Pharmaceuticals Inc (IONS) — Strategic Asset Allocation Index
Ionis Pharmaceuticals Inc (IONS) has a Strategic Asset Allocation Index of 21.4% as of June 2023. Strategic assets (PP&E of $91.63 Million plus long-term investments of $-) total $91.63 Million, measured against net assets of $428.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Ionis Pharmaceuticals Inc (IONS) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ionis Pharmaceuticals Inc Strategic Asset Allocation Index (2000–2022)
This chart shows how Ionis Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of June 2023, the index stands at 21.4%, representing strategic assets of $91.63 Million against net assets of $428.30 Million USD. See financial agility of Ionis Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ionis Pharmaceuticals Inc (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ionis Pharmaceuticals Inc from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IONS stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 13.0% | $74.29 Million | $74.29 Million | $- | $572.89 Million | ▼ -10.1 pp |
| 2021 | 23.1% | $178.07 Million | $178.07 Million | $- | $772.00 Million | ▲ +1.6 pp |
| 2020 | 21.5% | $181.08 Million | $181.08 Million | $- | $843.00 Million | ▲ +11.8 pp |
| 2019 | 9.7% | $163.65 Million | $153.65 Million | $10.00 Million | $1.69 Billion | ▼ -1.4 pp |
| 2018 | 11.1% | $132.16 Million | $132.16 Million | $- | $1.19 Billion | ▼ -18.0 pp |
| 2017 | 29.1% | $121.91 Million | $121.91 Million | $- | $418.72 Million | ▼ -64.1 pp |
| 2016 | 93.3% | $92.84 Million | $92.84 Million | $- | $99.56 Million | ▲ +48.3 pp |
| 2015 | 44.9% | $90.23 Million | $90.23 Million | $- | $200.79 Million | ▲ +10.4 pp |
| 2014 | 34.5% | $88.96 Million | $88.96 Million | $- | $257.78 Million | ▲ +11.7 pp |
| 2013 | 22.8% | $86.20 Million | $86.20 Million | $- | $378.39 Million | ▼ -27.1 pp |
| 2012 | 49.8% | $91.08 Million | $91.08 Million | $- | $182.77 Million | ▼ -6.5 pp |
| 2011 | 56.4% | $96.61 Million | $96.61 Million | $- | $171.43 Million | ▲ +41.8 pp |
| 2010 | 14.6% | $35.70 Million | $35.70 Million | $- | $244.54 Million | ▲ +5.5 pp |
| 2009 | 9.1% | $27.34 Million | $27.34 Million | $- | $302.06 Million | ▼ -7.6 pp |
| 2008 | 16.7% | $17.37 Million | $17.37 Million | $- | $104.25 Million | ▼ -53.0 pp |
| 2007 | 69.6% | $7.13 Million | $7.13 Million | $- | $10.24 Million | ▲ +62.3 pp |
| 2006 | 7.3% | $7.16 Million | $7.16 Million | $- | $97.90 Million | ▼ -335.3 pp |
| 2005 | 342.6% | $9.13 Million | $9.13 Million | $- | $2.67 Million | ▲ +290.8 pp |
| 2003 | 51.8% | $34.79 Million | $34.79 Million | $- | $67.18 Million | ▲ +13.8 pp |
| 2002 | 38.0% | $59.09 Million | $59.09 Million | $- | $155.48 Million | ▲ +25.3 pp |
| 2001 | 12.7% | $28.25 Million | $28.25 Million | $- | $223.10 Million | ▼ -21.4 pp |
| 2000 | 34.1% | $22.62 Million | $22.62 Million | $- | $66.37 Million | — |